O'Shares Investment Advisers’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-44,098
Closed -$4.89M 146
2022
Q1
$4.89M Buy
44,098
+2,461
+6% +$260K 0.39% 53
2021
Q4
$4.31M Buy
41,637
+3,027
+8% +$351K 0.31% 87
2021
Q3
$4.84M Sell
38,610
-21,043
-35% -$2.72M 0.36% 83
2021
Q2
$7.41M Buy
59,653
+1,558
+3% +$196K 0.52% 59
2021
Q1
$6.86M Sell
58,095
-215
-0.4% -$25.2K 0.51% 61
2020
Q4
$6.83M Buy
58,310
+5,533
+10% +$609K 0.52% 69
2020
Q3
$5.49M Buy
52,777
+13,389
+34% +$1.34M 0.57% 54
2020
Q2
$3.61M Sell
39,388
-13,209
-25% -$1.27M 0.45% 61
2020
Q1
$4.74M Sell
52,597
-39
-0.1% -$4.15K 0.85% 30
2019
Q4
$5.97M Buy
52,636
+2,726
+5% +$299K 0.82% 32
2019
Q3
$5.42M Buy
49,910
+4,813
+11% +$502K 0.82% 30
2019
Q2
$4.39M Buy
45,097
+2,635
+6% +$241K 0.7% 34
2019
Q1
$3.87M Buy
42,462
+966
+2% +$86.5K 0.66% 36
2018
Q4
$3.77M Buy
+41,496
New +$3.88M 0.72% 33

Other funds holding MDT

O'Shares Investment Advisers's MDT Position: Q2 2022 in Review

O'Shares Investment Advisers sold out of Medtronic (MDT) in Q2 2022, closing a stake of 44,098 shares — an estimated $4.89M sold.

O'Shares Investment Advisers first reported a position in MDT in Q4 2018 and held it in 14 quarters. The position peaked at $7.41M in Q2 2021. 2,022 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

  • O'Shares Investment Advisers reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
  • O'Shares Investment Advisers sold 44,098 Medtronic shares in Q2 2022, an estimated $4.89M.
  • O'Shares Investment Advisers first reported a position in Medtronic in Q4 2018 and held it in 14 quarters.
  • O'Shares Investment Advisers's Medtronic position peaked at $7.41M in Q2 2021.
  • 2,022 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on O'Shares Investment Advisers's 13F filing for Q2 2022.